elizabethwang+FollowWegovy Pill’s Wild First Week!Novo Nordisk’s new Wegovy weight-loss pill just dropped in the US and people are already obsessed—over 18,000 prescriptions in its first week! That’s way more than their old injectable version or Lilly’s rival drug managed at launch. The big deal? It’s a pill, not a shot, so it’s way more convenient. Investors are watching closely, and it looks like the weight-loss pill race is officially on! #Health #BodyHealth #Wegovy10Share
Michelle Chen+FollowWegovy Pill Prescriptions Are Flying Off ShelvesNovo Nordisk’s new Wegovy weight-loss pill just hit 3,071 prescriptions in its first four days—and that’s not even counting the online orders! Investors are watching closely to see if Novo can keep its edge over Eli Lilly in the super-competitive weight-loss market. This launch is already making waves, and the real numbers could be even higher. Would you try it? #Health #BodyHealth #Wegovy110Share
Annette Young+FollowWeight Loss Drugs: The Rebound Is RealWeight loss meds like Ozempic and Wegovy have been game-changers, but a new study says the pounds (and health risks) come back fast after you stop. Most people regain their lost weight within two years, and blood pressure and cholesterol bounce back even sooner. Even the newer GLP-1 drugs aren’t immune—folks lose more at first, but it all evens out in the end. Looks like the weight loss magic only lasts as long as you’re on the meds! #Fitness #Ozempic #Wegovy30Share
Joshua Morris+FollowWeight Loss Jabs: The Fast Track to Yo-Yo?Major study alert: people using fat loss jabs like Wegovy and Mounjaro drop pounds fast, but as soon as they stop, the weight comes back even quicker—almost four times faster than with old-school diet and exercise! Plus, all those health perks (like better blood sugar and cholesterol) vanish too. Experts say you might need to stay on these meds for life, or combine them with real lifestyle changes, to keep the results. Not exactly the magic fix everyone hoped for! #Fitness #WeightLoss #Wegovy00Share
Adam Cox+FollowWegovy Pill Just Dropped in the US!GLP-1 drug market is getting a major shakeup! The first-ever Wegovy pill for obesity is now on shelves in the US, starting at $149/month for self-pay. More options, more ways to pay, and even stronger injectables are coming. Plus, some drugs are getting the boot while others are showing promise in trials. Big changes for anyone following weight loss meds! #Health #BodyHealth #Wegovy10Share
Jeffrey Miller+FollowWegovy Pill: No More Needles!Weight loss just got a whole lot easier—Wegovy, the popular weight-loss drug, is now available as a daily pill instead of just a weekly injection. The FDA just approved it, so if needles made you hesitate, this could be a total game-changer. Would you try the pill version? #Fitness #Wegovy #WeightLoss50Share
Jeffrey Miller+FollowWegovy Pill: Game-Changer for Weight Loss?The FDA just approved a daily Wegovy pill for weight loss—no more needles! It’s the same ingredient as the popular shots, but now in a once-a-day tablet. In trials, people lost about 13.6% of their body weight over 15 months. Pills could make weight-loss meds way more accessible (and maybe cheaper). Would you try a daily pill if it meant ditching injections? #Fitness #Wegovy #WeightLoss70Share
Kristin Shaw+FollowIs Wegovy the Next Big Weight Loss Hack?If you’ve been eyeing a little help with weight loss, here’s some buzz: Europe’s health watchdog just gave a thumbs up to a higher dose of Wegovy, a popular weight-loss shot. Early results? Folks are dropping over 20% of their body weight—without losing muscle. If this gets approved everywhere, expect more people swapping fad diets for a weekly shot. Could this be the end of yo-yo dieting? #Business #Industry #Wegovy00Share
nathan87+FollowWegovy Pill Just Blew Up the Weight-Loss GameNovo Nordisk’s new Wegovy pill just set a wild record—prescriptions shot up nearly 500% in week two, totally crushing every other GLP-1 launch (even Eli Lilly’s Zepbound). And get this: the real numbers are probably way higher because they don’t even count direct-to-consumer or telehealth sales. Pills are about to make weight-loss meds mainstream, and Novo just sprinted ahead of the competition. Pharma drama, anyone? #Health #BodyHealth #Wegovy01Share
